Garg N, Tellier G, Vale N, Kluge J, et al. Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults. PLoS One 2024;19:e0303450.
PMID: 38843267